Quantcast

Pharmaceutical industry remains active

With the increased cost and complexity of performing research and development (R&D), many strategic acquirers are using M&A as their R&D pipeline making for a very active M&A market in the pharmaceutical space, says Geoff Raker, a partner with Tailwind Capital.

« Previous12345Next »